JACC:心梗后的炎性反应对大脑和心脏的功能有明显影响

2018-01-19 MedSci MedSci原创

急性心梗后的局部炎性组织反应对最后的预后结果起到重要作用,全身作用引起的神经性炎症是神经退行性疾病的前兆。本研究的目的旨在通过非侵入性的正电子发射断层扫描(PET)评估心梗对心脏和大脑炎性反应的影响。本研究在对小鼠进行冠脉结扎或者假手术处理后,对所有小鼠(n=49)进行了全身线粒体转运蛋白(TSPO)的PET扫描,TSPO作为标记激活巨噬细胞和小胶质细胞的标志物,同时,急性心梗后的病人(n=3)也

急性心梗后的局部炎性组织反应对最后的预后结果起到重要作用,全身作用引起的神经性炎症是神经退行性疾病的前兆。本研究的目的旨在通过非侵入性的正电子发射断层扫描(PET)评估心梗对心脏和大脑炎性反应的影响。

本研究在对小鼠进行冠脉结扎或者假手术处理后,对所有小鼠(n=49)进行了全身线粒体转运蛋白(TSPO)的PET扫描,TSPO作为标记激活巨噬细胞和小胶质细胞的标志物,同时,急性心梗后的病人(n=3)也与正常对照(n=9)进行了比较。结果显示,与假手术组相比,冠脉结扎手术后的小鼠线粒体转运蛋白明显升高(8.0 ± 1.6 vs. 4.8 ± 0.9; p < 0.001),早期的TSPO可以预测术后8周的左室重塑水平。同时,冠脉结扎小鼠的大脑TSPO在术后1周也有升高(1.7 ± 0.2 vs. 1.4 ± 0.2 ; p = 0.017),4周后逐渐降低,而心衰促使了第二波的神经炎性反应。术后8周的心室重塑时期,TSPO也有升高,但是没有炎症细胞的浸润,提示了线粒体功能的受损。血管紧张素转换酶抑制剂治疗可降低心脏急性炎症(P=0.003)和大脑急性炎症(P=0.06),并且改善晚期心功能。此外,急性心梗病人的心脏梗死区域的TSPO信号也有增高。

研究结果显示,大脑容易受急性心梗和慢性心衰的影响,免疫系统的激活可以影响大脑和心脏的功能障碍。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1853909, encodeId=6bf218539094d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 05 21:48:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053407, encodeId=3514205340e03, content=<a href='/topic/show?id=93255105e89' target=_blank style='color:#2F92EE;'>#心梗后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51057, encryptionId=93255105e89, topicName=心梗后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Aug 19 05:48:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280614, encodeId=623c28061441, content=学习了谢谢分享学习!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jan 21 09:22:12 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325673, encodeId=912c13256e329, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Jan 21 01:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
    2018-07-05 hbwxf
  2. [GetPortalCommentsPageByObjectIdResponse(id=1853909, encodeId=6bf218539094d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 05 21:48:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053407, encodeId=3514205340e03, content=<a href='/topic/show?id=93255105e89' target=_blank style='color:#2F92EE;'>#心梗后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51057, encryptionId=93255105e89, topicName=心梗后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Aug 19 05:48:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280614, encodeId=623c28061441, content=学习了谢谢分享学习!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jan 21 09:22:12 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325673, encodeId=912c13256e329, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Jan 21 01:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
    2018-08-19 lfyang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1853909, encodeId=6bf218539094d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 05 21:48:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053407, encodeId=3514205340e03, content=<a href='/topic/show?id=93255105e89' target=_blank style='color:#2F92EE;'>#心梗后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51057, encryptionId=93255105e89, topicName=心梗后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Aug 19 05:48:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280614, encodeId=623c28061441, content=学习了谢谢分享学习!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jan 21 09:22:12 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325673, encodeId=912c13256e329, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Jan 21 01:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]
    2018-01-21 大爰

    学习了谢谢分享学习!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1853909, encodeId=6bf218539094d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Thu Jul 05 21:48:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053407, encodeId=3514205340e03, content=<a href='/topic/show?id=93255105e89' target=_blank style='color:#2F92EE;'>#心梗后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51057, encryptionId=93255105e89, topicName=心梗后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43cb463, createdName=lfyang, createdTime=Sun Aug 19 05:48:00 CST 2018, time=2018-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280614, encodeId=623c28061441, content=学习了谢谢分享学习!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Jan 21 09:22:12 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325673, encodeId=912c13256e329, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Jan 21 01:48:00 CST 2018, time=2018-01-21, status=1, ipAttribution=)]

相关资讯

JCEM:将小腿围加入代谢综合征组分对心血管风险的影响!

由此可见,与MetS的传统定义相比,将CC加入MetS组分有更高的心血管和全因死亡风险。

JACC:EGFR抑制剂是治疗动脉粥样硬化潜在的新靶点

几种表皮生长因子受体(EGFR)抑制剂被成功用于肿瘤的治疗,抑制肿瘤的生长和代谢。然而EGFR也表达于白细胞,其在免疫调节中的角色尚未阐明。本研究的目的旨在评估表达于CD4+ T细胞的EGFR是否有功能,并探究EGFR抑制剂在动脉粥样硬化中的作用及机制。本研究中用的EGFR抑制剂为AG-1478(埃罗替尼),并利用Ldlr-/-Cd4-Cre/Egfrlox/lox小鼠模型在小鼠CD4+ T细胞中

JACC:ICD可以用于Brugada综合征青少年患者吗?

患有Brugada综合征的年轻患者发生室性心律失常的风险很高,植入型心律转复除颤器(ICD)可以较好地预防这种风险,然而这种治疗方法可能会引起植入设备相关并发症和误放电。本研究的目的旨在评估植入有ICD的Brugada综合征年轻患者的临床特征、管理以及预后。本研究纳入了35例年龄≤20岁的植入ICD的Brugada综合征患者,植入ICD的平均年龄为13.9 ± 6.2岁,92%的患者有较明显的临床

发烧小问题?它可能会引起小儿血管疾病并导致死亡!

本病为一种急性全身性血管炎,以婴幼儿发病为主,有持续性发热、皮疹、淋巴结炎等特征性表现。本病是引起儿童获得性心血管疾病的两个主要因素之一,在许多地方其危险性甚至大于风湿热。 病史: 患者为一4岁男童,平素体健,生长发育情况良好,入院前1个半月,患儿患水痘,15天后水痘逐渐消退。患儿5天前,着凉后出现发热,体温最高38.5度,伴寒战、眼红、口唇干裂,无呼吸困难、咳嗽、吐泻、抽搐等表现,当地医

心血管病风险评估|预测远期风险 指导当下策略

心血管病总体风险的评估是指根据心血管病多种危险因素的水平高低和组合,来判断或预测一个人或一群人未来发生心血管病急性事件的概率。它已被国内外相关指南广泛采用,在临床实践和人群防治中均发挥了重要指导作用。近两年我国学者更新发布的《中国成人血脂异常防治指南》《中国心血管病预防指南》也更多强调了心血管风险评估的重要性。

JACC:左心耳封堵术对患者神经内分泌系统有明显影响!

左心耳封堵(包括心外膜封堵装置和心内膜封堵装置)对患者全身稳态的影响尚属未知。本研究的目的旨在评估左心耳封堵对患者神经体液的影响,主要是对肾素-血管紧张素-醛固酮系统与自主神经系统的影响。本前瞻性单中心观察性研究纳入了77名行左心耳封堵术(包括38名心外膜和39名心内膜封堵装置)的患者,并对所有患者术前、术后即刻、术后24h和术后3个月的关键激素水平包括肾上腺素能系统、肾素血管紧张素醛固酮系统、代